Perceptions of Marijuana Use for Glaucoma from Patients, Cannabis Retailers, and Glaucoma Specialists

Weldy, Eric W.; Stanley, Jennifer; Koduri, Vivek A.; McCourt, Emily A.; Patnaik, Jennifer L; Kahook, Malik Y.; Seibold, Leonard K.

doi:10.1016/j.ogla.2020.06.009

Cited by 3 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…They found that only a small minority of AGS members (7.6%) recommended marijuana for glaucoma management, while a majority (51%) of surveyed MMJ dispensaries in Colorado endorsed the use of MMJ for glaucoma. They also reported that a majority of surveyed patients had heard about the potential role of marijuana in glaucoma management 13. Their research implies that there is likely a large population of patients, who have heard about MMJ for glaucoma management, but may be receiving conflicting information from ophthalmologists and marijuana dispensaries.…”

Section: Discussionmentioning

confidence: 97%

“…They also reported that a majority of surveyed patients had heard about the potential role of marijuana in glaucoma management. 13 Their research implies that there is likely a large population of patients, who have heard about MMJ for glaucoma management, but may be receiving conflicting information from ophthalmologists and marijuana dispensaries. The previous study addressed patterns of recommending MMJ as a treatment for glaucoma.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Attitudes and Perceptions Toward the Use of Medical Marijuana by Glaucoma Specialists

Bergman

Douglas

Wang³

et al. 2021

Journal of Glaucoma

View full text Add to dashboard Cite

Précis: With expanding legality of medical marijuana (MMJ) in the United States, it is important for ophthalmologists to have greater understanding of the implications of MMJ and glaucoma treatment and how it can impact their patients.Purpose: Previous work has demonstrated that inhaled tetrahydrocannabinol can lower intraocular pressure. The stance of the American Glaucoma Society (AGS) is that MMJ is not an acceptable treatment for glaucoma. The purpose of this study is to evaluate the glaucoma specialists' perceptions and attitudes toward the use of MMJ for glaucoma.Methods: An electronic survey was sent to members of the AGS which addressed attitudes and perceptions on the use of MMJ in the management of glaucoma. Study questions included practitioner demographics, previous experiences with patients discussing the topic, prescribing patterns, and knowledge regarding the use of MMJ for the treatment of glaucoma.Results: Thirty-seven percent of respondents reported having patients who cited using MMJ for their glaucoma, and 38% of respondents were asked about MMJ by their patients at least once per week. Fifty-five percent of respondents had patients who asked them for MMJ prescriptions. When asked if they felt if there was a possible role for marijuana in the management of glaucoma patients, 27% of survey takers responded yes. Fourteen percent of survey respondents kept information on MMJ in their office. Finally, 76% of participants responded they would be interested in additional education on the topic.Conclusions: Over 25% of the glaucoma specialists responded that MMJ had a role in the treatment of glaucoma, despite the recommendation of the professional society. This group was least likely to have received education on the topic. Given the expanding legality and curiosity of patients with regards to marijuana in the United States, it is important for ophthalmologists to have a greater understanding of the implications of marijuana in glaucoma.

show abstract

Section: Discussionmentioning

confidence: 97%

Section: Discussionmentioning

confidence: 99%

Attitudes and Perceptions Toward the Use of Medical Marijuana by Glaucoma Specialists

Bergman

Douglas

Wang³

et al. 2021

Journal of Glaucoma

View full text Add to dashboard Cite

show abstract

“…To our knowledge, however, no study has quantified this discrepancy in opinions among the general public as compared with health care professionals. Physicians would highly benefit from recognizing the presence of such conflicting beliefs to facilitate more understanding and informational conversations with patients when educating them on potential glaucoma treatments 9 . This study aims to quantify how the perception of cannabinoid therapy for glaucoma differs among health care professionals, individual users, and other media accounts on Twitter.…”

mentioning

confidence: 99%

Public Perception of Marijuana Use for the Treatment of Glaucoma

Yakobashvili

Shah

Oydanich

et al. 2023

Journal of Glaucoma

View full text Add to dashboard Cite

The use of marijuana for the treatment of glaucoma has been widely debated amongst ophthalmologists and glaucoma specialists. Recent evidence suggests the majority of ophthalmologists do not support the use of marijuana as active treatment for glaucoma. However, there has been no investigation into understanding the public’s direct perception of the efficacy of marijuana in glaucoma treatment. By using Twitter as a tool to understand the public’s thoughts, tweets were analyzed over the last 2 years. Of the 700 tweets analyzed, 72% (n=503) of tweets were in favor of cannabis use in the treatment of glaucoma, whereas 18% (n=124) were evidently opposed. The majority of those in favor came from accounts of individual users (n=391; 56%) whereas those that opposed marijuana as a treatment came from accounts of health care media, ophthalmologists, and other health care workers. The discrepancy between the public and ophthalmologists and other health care professionals requires recognition and further action to better educate the public on the role of marijuana in glaucoma treatment.

show abstract

Attitudes and Knowledge Regarding the Therapeutic Use of Cannabinoids among Community Pharmacists: A Pilot Cross-Sectional Study in Amman, Jordan

Bazzari

2023

Healthcare

View full text Add to dashboard Cite

There is an increasing interest in the therapeutic use of cannabis worldwide, with a number of cannabinoid-derived drugs currently approved by the Food and Drug Administration (FDA) for certain indications. This study was conducted via a printed questionnaire and aimed to explore the attitudes and knowledge regarding the therapeutic use of cannabis and cannabinoids among community pharmacists residing in Amman, Jordan. The results revealed a neutral to low agreement level regarding the medical usefulness of cannabis; however, a higher agreement level was observed for FDA-approved cannabinoid-derived drugs. The majority of the participants reported that they did not learn enough regarding cannabinoids, do not adequately remember what they have learned, and do not actively look for information after graduation. The average percentages of correct identification of cannabis/cannabinoid FDA-approved drug indications, common adverse effects, interacting drugs, and cautions/contraindications were 40.6%, 53%, 49.4%, and 57.3%, respectively, with an overall correct identification rate of 51.1% of the participants. In conclusion, the results indicate an inadequate level of knowledge with a significant room for improvement regarding the various aspects of cannabinoid pharmacology.

show abstract

Perceptions of Marijuana Use for Glaucoma from Patients, Cannabis Retailers, and Glaucoma Specialists

Cited by 3 publications

References 13 publications

Attitudes and Perceptions Toward the Use of Medical Marijuana by Glaucoma Specialists

Attitudes and Perceptions Toward the Use of Medical Marijuana by Glaucoma Specialists

Public Perception of Marijuana Use for the Treatment of Glaucoma

Attitudes and Knowledge Regarding the Therapeutic Use of Cannabinoids among Community Pharmacists: A Pilot Cross-Sectional Study in Amman, Jordan

Contact Info

Product

Resources

About